Leerink Partnrs Lowers Earnings Estimates for Quanterix

Quanterix Co. (NASDAQ:QTRX) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for shares of Quanterix in a note issued to investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of ($0.98) per share for the year, down from their prior estimate of ($0.94). The consensus estimate for Quanterix’s current full-year earnings is ($0.98) per share. Leerink Partnrs also issued estimates for Quanterix’s Q4 2024 earnings at ($0.27) EPS, Q1 2025 earnings at ($0.58) EPS, Q2 2025 earnings at ($0.26) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.26) EPS, FY2025 earnings at ($1.33) EPS and FY2026 earnings at ($0.89) EPS.

Quanterix (NASDAQ:QTRX) last released its quarterly earnings data on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%.

Separately, TD Cowen upped their target price on shares of Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research note on Wednesday, November 13th.

Quanterix Price Performance

Shares of QTRX stock opened at $9.57 on Thursday. The stock has a market cap of $368.64 million, a PE ratio of -9.03 and a beta of 1.33. The stock has a 50-day moving average of $10.95 and a 200-day moving average of $12.43. Quanterix has a one year low of $8.21 and a one year high of $29.70.

Hedge Funds Weigh In On Quanterix

Institutional investors and hedge funds have recently modified their holdings of the business. Hsbc Holdings PLC lifted its stake in Quanterix by 34.7% in the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock valued at $164,000 after buying an additional 3,279 shares in the last quarter. Emerald Mutual Fund Advisers Trust boosted its stake in Quanterix by 0.8% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock worth $7,300,000 after purchasing an additional 4,406 shares during the period. nVerses Capital LLC acquired a new position in Quanterix in the 3rd quarter worth $60,000. Janney Capital Management LLC increased its holdings in Quanterix by 33.6% during the 3rd quarter. Janney Capital Management LLC now owns 23,553 shares of the company’s stock worth $305,000 after purchasing an additional 5,930 shares in the last quarter. Finally, American Century Companies Inc. raised its stake in shares of Quanterix by 14.5% in the 2nd quarter. American Century Companies Inc. now owns 56,145 shares of the company’s stock valued at $742,000 after purchasing an additional 7,118 shares during the period. 86.48% of the stock is currently owned by institutional investors and hedge funds.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.